Label-Free, Impedance-Based Biosensor for Kidney Disease Biomarker Uromodulin

Sensors (Basel). 2023 Dec 8;23(24):9696. doi: 10.3390/s23249696.

Abstract

We demonstrate the development of a label-free, impedance-based biosensor by using a passivation layer of 50-nm tantalum pentoxide (Ta2O5) on interdigitated electrodes (IDE). This layer was fabricated by atomic layer deposition (ALD) and has a high dielectric constant (high-κ), which improves the capacitive property of the IDE. We validate the biosensor's performance by measuring uromodulin, a urine biomarker for kidney tubular damage, from artificial urine samples. The passivation layer is functionalized with uromodulin antibodies for selective binding. The passivated IDE enables the non-faradaic impedance measurement of uromodulin concentrations with a measurement range from 0.5 ng/mL to 8 ng/mL and with a relative change in impedance of 15 % per ng/mL at a frequency of 150 Hz (log scale). This work presents a concept for point-of-care biosensing applications for disease biomarkers.

Keywords: atomic layer deposition; chronic kidney disease; impedance spectroscopy; tantalum pentoxide; uromodulin.

MeSH terms

  • Biomarkers
  • Biosensing Techniques*
  • Electric Impedance
  • Electrodes
  • Humans
  • Kidney
  • Kidney Diseases* / diagnosis
  • Uromodulin

Substances

  • Uromodulin
  • Biomarkers